Author:
Fafá Bárbara P., ,Louzada-Junior Paulo,Titton David C.,Zandonade Eliana,Ranza Roberto,Laurindo Ieda,Peçanha Paula,Ranzolin Aline,Hayata André L.,Duarte Angela,Silveira Inês G.,Costa Izaias,Macieira José C.,Guedes-Barbosa Luiz S.,Bertolo Manoel B.,Sauma Maria Fátima Lobato da C.,Silva Marília B. G.,Freire Marlene,Scheinberg Morton A.,Fernandes Vander,Bianchi Washington,Miranda José R. S.,Pinheiro Geraldo R. C.,Carvalho Hellen M. S.,Brenol Claiton Viegas,Pereira Ivanio A.,de Castro Gláucio Ricardo Werner,de Morais Júlio C. Bertacini,Oliveira Sheila K. F.,de Abreu Mirhelen Mendes,Toledo Roberto A.,Pinheiro Marcelo M.,Vieira Walber Pinto,Valim Valéria
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference26 articles.
1. Toussirot E, Wendling D (2007) The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 8(13):2089–107
2. Iannone F, Gremese E, Atzeni F, Biasi D, Botsios C, Cipriani P, Ferri C, Foschi V, Galeazzi M, Gerli R, Giardina A, Marchesoni A, Salaffi F, Ziglioli T, Lapadula G, Gruppo Italiano di Studio sulle Early Arthritides (GISEA) (2012) Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors. J Rheumatol 39(6):1179–84
3. Carmona L, Gómez-Reino JJ, BIOBADASER Group (2006) Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther 8(3):R72
4. Martínez-Santana V, González-Sarmiento E, Calleja-Hernández M, Sánchez-Sánchez T (2013) Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis. Patient Prefer Adherence 29(7):719–27
5. Scirè CA, Caporali R, Sarzi-Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, Govoni M, Gerli R, Raschetti R, Minisola G, Montecucco C, Todesco S (2013) Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet Database. Clin Exp Rheumatol 31(6):857–63